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Abstract
In 2008, Pienta et al. (Transl Oncol. 2008;1:158–164) introduced the term ecological therapy for cancer treatment
and, in particular, emphasized that destruction of the tumor microenvironment would be more effective than just
killing the cells that inhabit it. Proposed here is an expansion on the idea of ecological therapy of cancer, incorpo-
rating 1) literature on species invasion, i.e., a right cancerous clone needs to be at the right place at the right time to
actually invade its environment, and 2) the literature on niche construction, that is, the idea that once a tumor is
formed, cancer cells they modify their microenvironment (niche construction) by changing pH through glycolysis, se-
creting growth factors and recruiting tumor-associated macrophages to promote cell growth, activating fibroblasts,
evading predation from immune system, making the cancer that much more difficult to eradicate. Paleontological
literature suggests that the largest mass extinctions occurred when environmental stress that would weaken the pop-
ulation was coupled with some pulse destructive event that caused extensive mortality. To have the same effect on
cells in the tumor, rather than, or at least in addition to, killing the cells, one would also need to target the niche that
they created for themselves.
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Cancer as an Ecological System
During the past decade, it has become increasingly recognized that a
tumor is not genetically homogeneous but is rather composed of
many genetically diverse cancer cells [1,2]. If variability in the pop-
ulation is heritable and if it affects fitness, then the system is going to
evolve, leading to competition for space and common resources and
resulting in different clones being selected for or weeded out of the
population due to natural selection. Genomic heterogeneity is one of
the major reasons why we see acquired therapeutic resistance because
cytotoxic therapy inevitably selects for resistant cells by applying a
severe selective pressure on the entire heterogeneous cell population.
Moreover, heterogeneity within even premalignant lesions has been
shown to be indicative of a worse prognosis for the patient [3]. At the
same time, prognosis for young cancer patients is typically more
favorable, which can be attributed in part to the fact that younger
tumors are less heterogeneous and hence are less likely to become
resistant to therapy.
Another consequence of tumor heterogeneity is the possibility of
so-called evolutionary suicide [4]—in their quest for higher growth
rates, lower death rates, and increased competitiveness and with their
ability to migrate out and colonize distant organs, cancer cells defy
“cooperation” with somatic tissue, eventually killing the host and thus
killing themselves. This evolutionary experiment is run within each
cancer patient, sometimes leading to cancer cells committing evolu-
tionary suicide at the expense of the host.
From an ecological perspective, one can look at this process as an
attempt of new species (cancer cells), which have different metabolic
and reproductive strategies compared with the “resident” population
(somatic cells) to invade a new habitat (tissue). Successful invasion will
result in the formation of a primary solid tumor. Such perspective
might be able to provide a different viewpoint, allowing us to draw par-
allels with other ecological systems to find answers to such questions as
“under what conditions can invasions occur?,” “how do invading spe-
cies adapt to and modify their environment?,” and, most importantly,
“what can be done to eradicate them?”
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Mechanisms of Species Extinction
The mechanisms by which species in nature go extinct can generally
be subdivided into two distinct categories—extrinsic factors, such as
habitat modification, change in nutrient supply, and interactions
with predators; and intrinsic factors, such as any change in the geno-
type, which eventually results in changes in the phenotype.
Intrinsic factors typically reflect how the species have been adapt-
ing to their environment over a long evolutionary time scale. From
an evolutionary game theory point of view, individuals within the
population have been moving toward an evolutionarily stable strategy
(ESS), that is, a state when no individual within the population has
an incentive to change his/her “strategy” in his/her interactions with the
environment. As a result, theoretically, once the ESS is adopted in the
population, natural selection alone becomes insufficient to allow inva-
sion by a newmutant. (It is important to note that being at an ESS does
not imply highest fitness in the sense of the largest difference between
birth and death rates. It only implies resistance to invasion.)
However, invasions do happen. One of the frequent ways by
which species can go extinct is when a more efficient or more pro-
liferative competitor invades their habitat much like cancerous cells
can invade and start outcompeting healthy cells in the tissues. Re-
search in the area of invasion ecology has been focused particularly
on this question.
Habitat Invasion and Cancer
A number of mechanisms have been proposed to explain why some
habitats are more or less susceptible to invasion, of which habitat
modification is most often the common denominator [5–7]. Invasion
can be facilitated when the “native” populations are more specialized
toward their niche, whereas the invaders are “generalists”—perhaps
less efficient in some aspects when compared with the natives but
capable of taking on multiple roles and exploiting multiple resources
[8,9]. Another, perhaps complementary, theory comes from David
Tilman, whose research focus has primarily been on the questions
of ecosystem stability and the effects on it of biodiversity. He suggests
that ecosystems that are more diverse are less susceptible to invasion
because greater biodiversity ensures more complete resource utiliza-
tion [7,10,11]. Incomplete resource utilization allows for the forma-
tion of a new niche, which can be occupied by invaders. And, if the
new niche has been available for an extended period, invaders not only
will have time to find and occupy it but also will be able to “coevolve
with it.” This phenomenon is known as niche construction [12], and
it refers to a situation when the niche gets modified because of the
metabolic activity of its occupants. The adaptations could also be dif-
ferent: an invader can modify the niche to be better suited for them
than for any other species or it can exploit the niche in such a way
as to make it uninhabitable by anyone, inducing increased mi-
gration (which could be an ecological explanation for the formation
of metastases).
When it comes to cells within a tissue, one can argue that they
are at an evolutionarily stable state and thus should not be prone
to invasion by a cell that adapts a different metabolic or reproduc-
tive strategy. Another way of thinking about the “normal” state of
cells in the tissue is that they are at an adaptive peak [13]. There-
fore, in order for a cancerous clone to invade the population of
healthy cells, something must take the healthy cells “off of the adap-
tive peak.”
It has been suggested [13–15] that aging is one such mechanism by
which the somatic cells gradually slide off of the adaptive peak, allow-
ing for the invasion of cancerous clones. It is possible that aging-
associated decline in functionality of cells, tissues, and organs, caused
by both intrinsic cell mechanisms, such as accumulated mutations, as
well as damage caused by extrinsic factors, such as exposure to carcin-
ogens, could be reducing fitness of the resident cell population over
time. Some studies also suggest that mitochondrial function declines
with age, possibly because of the accumulated damage from exposure
to reactive oxygen species during the individual’s life span [16–22].
Because most aerobic metabolism occurs in mitochondria, decline
in mitochondrial function would cause loss of fitness advantage for
somatic cells. If, for cancer initiation, one needs to not only have
the right cancer clone (identification of what makes the right clone
is the focus of molecular study of cancer genetics) but also have it
in the right place at the right time, aging could provide the ever-
increasing window of that “right time.”
Niches in a Human Body
It is, of course, not completely clear what defines a niche for a cell
population in a human body. If one were to continue with the eco-
logical analogy, one would have to include in the definition of nutri-
ents (glucose, phosphorus, iron, lipids, and other materials necessary
for cell growth and reproduction), space (including extracellular ma-
trix, which is often destroyed by tumors), and predators (cells of the
immune system), as well as other microorganisms, such as gut or skin
bacteria. The niche would also be characterized by such factors as pH,
blood flow, and rates at which cell metabolic products, dead cells, as
well as external chemicals, such as certain carcinogens, are being
washed out from the tissue. Other inhabitants of the niche, in this
case the somatic cells, are, of course, also part of the environment.
So, a significant modification in either of these components could
hypothetically allow for the creation of a new niche that a budding
primary tumor can occupy.
Interactions with the Predator:
The Immune System
Many tumors are characterized by increased inflammation [23–26]. It
is possible that, while the immune system is fighting an infection, im-
mune cells secrete growth factors that premalignant cells also partake
in, thus creating new growth factor–rich microenvironment [27,28].
If the inflammation, and thus inflow of growth factors, continues long
enough, it can give the few cancerous clones the boost they need to
start growing. A subsequent decrease in the inflammatory response
may not be enough to stop the tumor from growing once the process
has been initiated because some tumors either learn to secrete their
own growth factors (the so-called hormone-secreting tumors like pi-
tuitary adenoma) or learn to manipulate other cells to secrete growth
factors for them. A striking example of the latter is the existence of
tumor-associated macrophages (TAMs) that accumulate preferentially
in the poorly vascularized regions of tumors [26,29,30] and secrete
cytokines that actually promote tumor growth [24,28,29,31]. More-
over, not only can these cytokines promote tumor growth but they
have also been known to suppress activation of CD8+ T cells that
are most efficient in tumor elimination [32–36].
Cancer-Induced Niche Modification
Thus, tumor cells, after invading a newly formed niche, have ample
ways to modify it as to make it suit their particular needs. A possible
unifying mechanism could be as follows: a right cell (exhibiting one or
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more hallmarks of cancer) has been in the right place (having access to
enough nutrients, such as carbon and phosphorus and other building
materials) at the right time (during cell division or inflammation, get-
ting access to growth factors, or simply in an older tissue, where the
surrounding cells are not as fit). As the primary tumor outgrows its
blood supply, an increasing number of cells switch to glycolytic me-
tabolism. Glycolytic cells secrete lactic acid as a by-product of glucose
metabolism, creating acidic microenvironment, which can become
toxic to surrounding somatic cells [37–39], thus giving glycolytic can-
cer cells the competitive advantage even in the presence of oxygen.
Normally, glycolysis is upregulated only in a hypoxic microenvi-
ronment, where production of protein hypoxia-inducible factor 1
(HIF-1) is upregulated; under normoxic conditions, its oxygen-sensitive
part HIF-1α is degraded through the ubiquitin-proteasome pathway
[40,41]. However, in hypoxia, the presence of HIF-1α stimulates
production of vascular endothelial growth factor (VEGF) and other
angiogenesis-promoting factors to stimulate blood flow and bring in
more oxygen to the supposedly hypoxic areas [40].
In the presence of a large enough number of glycolytic cells, an
acidic microenvironment is created, in which HIF-1 production is up-
regulated, and, what is more important, HIF-1α, the oxygen-sensitive
part of HIF-1, is not degraded. Lu et al. [42] provide evidence that
lactate and pyruvate regulate hypoxia-inducible gene expression inde-
pendently of hypoxia by stimulating the accumulation of HIF-1α at
the site. It seems like the function of von Hippel–Lindau protein, a
site of HIF-1α recognition by the proteosomes, is neutralized both in
hypoxic conditions and in the areas of normoxic acidosis, thus allow-
ing tumors to simulate hypoxia in normoxic conditions [43].
What does this lead to? Corzo et al. [44] showed that when HIF-1
is upregulated, activation of CD8+ T cells is suppressed, and expres-
sion of TAMs goes up. Also, HIF-1, because its primary purpose
is to attract oxygen to hypoxic areas, stimulates production of
VEGF, which has a number of different effects. For one, VEGF
not only promotes angiogenesis but also downregulates activation
of CD8+ T cells, allowing the tumor to grow unrestrained by the
immune system [32].
The process can be summarized as follows (see also Figure 1):
1) A mutated cell survives and starts proliferating in the tissue.
Faced with decreasing oxygen availability, cells within the tumor
start switching to glycolytic metabolism, which results in the cre-
ation of acidic microenvironment around the tumor.
2) HIF-1 is upregulated even in normoxic conditions, because
von Hippel–Lindau protein, a binding site for HIF-1α–degrading
proteosomes, becomes neutralized in areas of hypoxia and nor-
moxic acidosis, thus allowing the tumor to simulate hypoxia in
normoxic conditions. It has been shown that by-products of
glycolysis, lactate and pyruvate, allow up-regulation of HIF-1 even
in normoxia.
3) As the production of HIF-1 increases, activation of CD8+ T cells
decreases (immune system evasion), and recruitment of TAMs
increases, thus providing more growth factors for tumor cells.
4) As HIF-1 concentration increases, so does the production of
VEGF because the main purpose of HIF-1 is to attract more
blood vessels to restore oxygen supply, thus promoting angio-
genesis. VEGF has also been shown to downregulate CD8+ T-cell
Figure 1. Schematic representation of the possible mechanism of tumor initiation and progression from an ecological point of view.
Tumor initiation corresponds to the mechanism of species invasion and is hypothesized to be possible when the environment is per-
missive, in particular, when there are excess nutrients (new niche) and when competitors (somatic cells) are less fit compared with the
invaders. Tumor promotion corresponds to niche colonization and modification by the invading species through pH alteration, recruit-
ment of growth factors, and others, as well as avoidance of predators (immune suppression).
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activation through suppression of maturation of antigen-presenting
cells, such as dendritic cells, thus also suppressing the antitumor
immune response.
Reverse Conservation Biology and Mass
Extinctions: Lessons from Paleontology
A naturally arising question is then: “If a niche has been created, and if
the tumor cells had had the chance to occupy it and settle in it, how
can one get rid of them?” Just reversing the initial conditions that had
led to the formation of the niche might not be sufficient because, as it
was pointed out previously, the tumor cells themselves had the chance
to modify their microenvironment. Just targeting the population of
tumor cells would also simply free up the space and nutrients to be used
by the resistant clones, which could have previously been held back
because of space and nutrient limitations, imposed on them by the less
aggressive but more abundant cell clones.
A possible answer to this question comes from paleontology and, in
particular, from the studies performed to analyze the conditions that
precede mass species extinctions that have occurred for the past several
million years. Arens and West [45] have suggested, based on their anal-
ysis of geologic record of impact factors and continental flood basalts,
that mass extinctions occurred more frequently and were more destruc-
tive, when pulse disturbances (such as marine anoxic incursions) that
cause extensive mortality, were accompanied by press disturbances
(such as climate or sea level change) that weakened and destabilized
populations over many generations preceding the pulse disturbance.
In cancer treatment, chemotherapy and radiation therapy act like
pulse disturbances for a population, causing extensive cell mortality
and, as a result, not only selecting for the resistant clones but also
freeing up the “niche” that can now be easily (or at least much easier
than before) colonized by them. Perhaps, weakening the population
through continuous microenvironmental stress before applying the
pulse would be more likely to cause mass extinction of cancer cells.
That is, rather than just kill the tumor cells, one also needs to elim-
inate their niche or at least make it less habitable for those cells that
might survive after therapy.
One way to do this could be to reverse the adaptations that the
tumor cells made for themselves. For instance, Robey et al. [46] dem-
onstrated in mouse models of metastatic breast cancer that neutral-
izing acidic tumor microenvironment with sodium bicarbonate
reduced formation of spontaneous metastases, an approach similar to
what J. Pepper termed targeting the public goods [47]. Counteracting
the cells’ attempts at modifying their microenvironment poses less of
a selective pressure on the cell population and is thus much less likely
to propagate evolution of resistant clones.
Blocking growth factors that facilitate tumor growth would be an-
other approach, whether tumors secrete them themselves or “steal”
them from tricked macrophages [28]. For instance, VEGF has been
identified to be a key mediator of angiogenesis in cancer: when tumors
start outgrowing their blood supply, they upregulate VEGF produc-
tion, which, in turn, promotes the formation of new blood vessels
[48]. Blocking VEGF receptors in tumors, accompanied by blocking
of c-met pathway, has been shown to halt tumor growth in mouse
models [49]. Not only could this be due to vasculature normalization,
which has been suggested to actually keep tumors from spreading
because their environment is acceptable enough for them to not need
to migrate out, but also because it is through growth factors like
VEGF that tumors suppress the activation of cytotoxic lymphocytes
by blocking the maturation of myeloid-derived suppressor cells
[32,34]. Thus as a side effect, there could be an additional activation
of the tumor-specific immune response coming from neutralizing
tumor-induced changes in the microenvironment.
It is also important to remember that different processes take place
on different time scales, and so they may be influencing each other in
less obvious ways than anticipated [50,51]. Biochemical and metabolic
reactions take place on the scale of seconds and minutes, whereas cell
growth and expansion occur on the scale of days. Hence, modification
of the environment that causes changes on one scale might have delayed
effects on the processes that take place on a different time scale.
Also, some nutrients can be functionally replaced (different carbon
sources), while others cannot—for instance, nothing but phosphorus
can be used for building of DNA, RNA, and ribosomes. Jin et al.
[52] conducted an experiment where an increased amount of phos-
phorus led to increased tumor growth in mouse models, supporting
the hypothesis that phosphorus could be a limiting reagent for cell
proliferation [53]. Changing the amount of phosphorus present
(through phosphorus enriched diet, for instance) would change the
composition of the cell microenvironment, creating a new niche for
phosphorus-greedy tumor cells to invade. Glucose transporters are
also highly upregulated in cancer cells to accommodate the high de-
mand for glucose [54], so a sustained diet that is high in carbohydrates
would also allow cancer cells to not worry about the drawbacks of
glycolysis. Caloric restriction has also been implied to improve mito-
chondrial function [55,56], so limiting carbohydrate intake could
hypothetically give somatic tissue back some competitive advantage
(benign boost).
Although changing what constitutes the “right cell” and the “right
time” may not be possible, the composition of the “right place,” the
microenvironment, could potentially be manipulated. Lessons from
ecology suggest that it could be of vital importance both for disease
prevention and for more successful treatment.
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